Abstract
National data on the COVID-19 outbreak in India is of limited use for nuanced analyses or informed policy interventions. The immense variation of the pandemic across states is obscured by our focus on national-level data and hampers assessment of effective policy measures.
We illustrate the masking of state-level trends by national data with a sample of 20 states that reported the highest number of COVID-19 cases by mid-May. Taken together, these 20 states accounted for more than 99% of the cumulative case and death counts in India on May 17, 2020. We highlight variation across states by presenting evidence on many crucial aspects of the COVID-19 outbreak from a public health point of view: case and death counts with case fatality rates; doubling times of cumulative number of cases; effective basic reproduction numbers; and the scale of testing.
Some interesting patterns of change over lockdown periods emerge. For example, the estimated effective reproduction number for India stood at 3.36 (95% confidence interval (CI): [3.03, 3.71]) on March 24, the day on which the lockdown was announced, whereas the average for the same over the week of May 12 - May 18 stands at 1.24 (95% CI: [1.22, 1.26]). Similarly, the estimated doubling time at an all-India level was at 3.56 days on March 24, and the past 7-day average for the same on May 18 is 13.08 days. The case fatality rate for India is estimated to be 3.25% (95% CI: [3.04%, 3.14%]) based on all confirmed cases, as of May 18. The average daily number of tests have increased from 1717 (March 19-25) to 99,403 (May 12-18) with test positivity rate during March 12-18 around 2.0% (Range: [1.3%, 2.4%]) and May 12-18 at an average of 3.9% (Range: [3.7%, 4.1%]). However, these overall national metrics do not reflect the state level heterogeneity. We present a comprehensive summary that can capture recent trends in all of these public health metrics across the states to aid a policymaker to titrate resources, set priorities and evaluate lockdown effects.
By looking at several public health and policy relevant measures, our framework offers a holistic picture of the pandemic across Indian states and union territories. Our analysis has a simple take-home message for analysts and policy makers. The COVID-19 outbreak in India, as in any other large country, displays large state-level variations. Identifying these variations can help in both understanding the dynamics of the pandemic and formulating effective public health policies of containment and mitigation. The visualization tools are available in our interactive application at covind19.org.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The research was supported by the University of Michigan Precision Health Initiative, University of Michigan School of Public Health, University of Michigan Institute for Health Care Policy and Innovation, Michigan Institute of Data Science and the University of Michigan Rogel Cancer Center. Effort of B Mukherjee was partially supported by NIH NCI grant P30 CA 046592.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All source code and interactive plots are available at covind19.org.
